Ignite Creation Date:
2024-07-17 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06481098
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2024-05-30
Brief Title:
A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects
Sponsor:
Hanmi Pharmaceutical Company Limited
Organization:
Hanmi Pharmaceutical Company Limited
Study Overview
Official Title:
A Randomized Double-Blind Placebo-Controlled Single- and Multiple-Ascending Dose Study to Assess Safety Tolerability Pharmacokinetics and Pharmacodynamics of HM15275 in Healthy and Obese Subjects
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This Study is a Phase 1 Study to Assess Safety Tolerability Pharmacokinetics and Pharmacodynamics of HM15275 in Healthy and Obese Subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None